Table of Content

1 Afutuzumab Market Overview
1.1 Afutuzumab Product Overview
1.2 Afutuzumab Market Segment by Type
1.2.1 Patent
1.2.2 Generic
1.3 Global Afutuzumab Market Size by Type
1.3.1 Global Afutuzumab Market Size Overview by Type (2024-2034)
1.3.2 Global Afutuzumab Historic Market Size Review by Type (2024-2024)
1.3.3 Global Afutuzumab Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Afutuzumab Sales Breakdown by Type (2024-2024)
1.4.2 Europe Afutuzumab Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Afutuzumab Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Afutuzumab Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Afutuzumab Sales Breakdown by Type (2024-2024)
2 Global Afutuzumab Market Competition by Company
2.1 Global Top Players by Afutuzumab Sales (2024-2024)
2.2 Global Top Players by Afutuzumab Revenue (2024-2024)
2.3 Global Top Players by Afutuzumab Price (2024-2024)
2.4 Global Top Manufacturers Afutuzumab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Afutuzumab Market Competitive Situation and Trends
2.5.1 Afutuzumab Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Afutuzumab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Afutuzumab as of 2022)
2.7 Date of Key Manufacturers Enter into Afutuzumab Market
2.8 Key Manufacturers Afutuzumab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Afutuzumab Status and Outlook by Region
3.1 Global Afutuzumab Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Afutuzumab Historic Market Size by Region
3.2.1 Global Afutuzumab Sales in Volume by Region (2024-2024)
3.2.2 Global Afutuzumab Sales in Value by Region (2024-2024)
3.2.3 Global Afutuzumab Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Afutuzumab Forecasted Market Size by Region
3.3.1 Global Afutuzumab Sales in Volume by Region (2024-2034)
3.3.2 Global Afutuzumab Sales in Value by Region (2024-2034)
3.3.3 Global Afutuzumab Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Afutuzumab by Application
4.1 Afutuzumab Market Segment by Application
4.1.1 Chronic Lymphocytic Leukemia
4.1.2 Follicular Lymphoma
4.2 Global Afutuzumab Market Size by Application
4.2.1 Global Afutuzumab Market Size Overview by Application (2024-2034)
4.2.2 Global Afutuzumab Historic Market Size Review by Application (2024-2024)
4.2.3 Global Afutuzumab Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Afutuzumab Sales Breakdown by Application (2024-2024)
4.3.2 Europe Afutuzumab Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Afutuzumab Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Afutuzumab Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Afutuzumab Sales Breakdown by Application (2024-2024)
5 North America Afutuzumab by Country
5.1 North America Afutuzumab Historic Market Size by Country
5.1.1 North America Afutuzumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Afutuzumab Sales in Volume by Country (2024-2024)
5.1.3 North America Afutuzumab Sales in Value by Country (2024-2024)
5.2 North America Afutuzumab Forecasted Market Size by Country
5.2.1 North America Afutuzumab Sales in Volume by Country (2024-2034)
5.2.2 North America Afutuzumab Sales in Value by Country (2024-2034)
6 Europe Afutuzumab by Country
6.1 Europe Afutuzumab Historic Market Size by Country
6.1.1 Europe Afutuzumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Afutuzumab Sales in Volume by Country (2024-2024)
6.1.3 Europe Afutuzumab Sales in Value by Country (2024-2024)
6.2 Europe Afutuzumab Forecasted Market Size by Country
6.2.1 Europe Afutuzumab Sales in Volume by Country (2024-2034)
6.2.2 Europe Afutuzumab Sales in Value by Country (2024-2034)
7 Asia-Pacific Afutuzumab by Region
7.1 Asia-Pacific Afutuzumab Historic Market Size by Region
7.1.1 Asia-Pacific Afutuzumab Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Afutuzumab Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Afutuzumab Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Afutuzumab Forecasted Market Size by Region
7.2.1 Asia-Pacific Afutuzumab Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Afutuzumab Sales in Value by Region (2024-2034)
8 Latin America Afutuzumab by Country
8.1 Latin America Afutuzumab Historic Market Size by Country
8.1.1 Latin America Afutuzumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Afutuzumab Sales in Volume by Country (2024-2024)
8.1.3 Latin America Afutuzumab Sales in Value by Country (2024-2024)
8.2 Latin America Afutuzumab Forecasted Market Size by Country
8.2.1 Latin America Afutuzumab Sales in Volume by Country (2024-2034)
8.2.2 Latin America Afutuzumab Sales in Value by Country (2024-2034)
9 Middle East and Africa Afutuzumab by Country
9.1 Middle East and Africa Afutuzumab Historic Market Size by Country
9.1.1 Middle East and Africa Afutuzumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Afutuzumab Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Afutuzumab Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Afutuzumab Forecasted Market Size by Country
9.2.1 Middle East and Africa Afutuzumab Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Afutuzumab Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 BOC Sciences
10.1.1 BOC Sciences Company Information
10.1.2 BOC Sciences Introduction and Business Overview
10.1.3 BOC Sciences Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.1.4 BOC Sciences Afutuzumab Products Offered
10.1.5 BOC Sciences Recent Development
10.2 Carbosynth
10.2.1 Carbosynth Company Information
10.2.2 Carbosynth Introduction and Business Overview
10.2.3 Carbosynth Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Carbosynth Afutuzumab Products Offered
10.2.5 Carbosynth Recent Development
10.3 Roche Group
10.3.1 Roche Group Company Information
10.3.2 Roche Group Introduction and Business Overview
10.3.3 Roche Group Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Roche Group Afutuzumab Products Offered
10.3.5 Roche Group Recent Development
10.4 TargetMol Chemicals
10.4.1 TargetMol Chemicals Company Information
10.4.2 TargetMol Chemicals Introduction and Business Overview
10.4.3 TargetMol Chemicals Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.4.4 TargetMol Chemicals Afutuzumab Products Offered
10.4.5 TargetMol Chemicals Recent Development
10.5 Wonda Science
10.5.1 Wonda Science Company Information
10.5.2 Wonda Science Introduction and Business Overview
10.5.3 Wonda Science Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Wonda Science Afutuzumab Products Offered
10.5.5 Wonda Science Recent Development
10.6 Absin Bioscience
10.6.1 Absin Bioscience Company Information
10.6.2 Absin Bioscience Introduction and Business Overview
10.6.3 Absin Bioscience Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Absin Bioscience Afutuzumab Products Offered
10.6.5 Absin Bioscience Recent Development
10.7 Chunchuang (Wuhan) Technology
10.7.1 Chunchuang (Wuhan) Technology Company Information
10.7.2 Chunchuang (Wuhan) Technology Introduction and Business Overview
10.7.3 Chunchuang (Wuhan) Technology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Chunchuang (Wuhan) Technology Afutuzumab Products Offered
10.7.5 Chunchuang (Wuhan) Technology Recent Development
10.8 Hubei Kele Fine Chemical
10.8.1 Hubei Kele Fine Chemical Company Information
10.8.2 Hubei Kele Fine Chemical Introduction and Business Overview
10.8.3 Hubei Kele Fine Chemical Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Hubei Kele Fine Chemical Afutuzumab Products Offered
10.8.5 Hubei Kele Fine Chemical Recent Development
10.9 Jiangxi Ruiweier Biotechnology
10.9.1 Jiangxi Ruiweier Biotechnology Company Information
10.9.2 Jiangxi Ruiweier Biotechnology Introduction and Business Overview
10.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Jiangxi Ruiweier Biotechnology Afutuzumab Products Offered
10.9.5 Jiangxi Ruiweier Biotechnology Recent Development
10.10 Qingdao Jieshikang Biotechnology
10.10.1 Qingdao Jieshikang Biotechnology Company Information
10.10.2 Qingdao Jieshikang Biotechnology Introduction and Business Overview
10.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Qingdao Jieshikang Biotechnology Afutuzumab Products Offered
10.10.5 Qingdao Jieshikang Biotechnology Recent Development
10.11 Shanghai Biochempartner
10.11.1 Shanghai Biochempartner Company Information
10.11.2 Shanghai Biochempartner Introduction and Business Overview
10.11.3 Shanghai Biochempartner Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Shanghai Biochempartner Afutuzumab Products Offered
10.11.5 Shanghai Biochempartner Recent Development
10.12 Shanghai Macklin Biochemical
10.12.1 Shanghai Macklin Biochemical Company Information
10.12.2 Shanghai Macklin Biochemical Introduction and Business Overview
10.12.3 Shanghai Macklin Biochemical Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Shanghai Macklin Biochemical Afutuzumab Products Offered
10.12.5 Shanghai Macklin Biochemical Recent Development
10.13 Shanghai Qiming Biotechnology
10.13.1 Shanghai Qiming Biotechnology Company Information
10.13.2 Shanghai Qiming Biotechnology Introduction and Business Overview
10.13.3 Shanghai Qiming Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Shanghai Qiming Biotechnology Afutuzumab Products Offered
10.13.5 Shanghai Qiming Biotechnology Recent Development
10.14 Shanghai Saimai Biotechnology
10.14.1 Shanghai Saimai Biotechnology Company Information
10.14.2 Shanghai Saimai Biotechnology Introduction and Business Overview
10.14.3 Shanghai Saimai Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Shanghai Saimai Biotechnology Afutuzumab Products Offered
10.14.5 Shanghai Saimai Biotechnology Recent Development
10.15 Shanghai Shize Biological Technology
10.15.1 Shanghai Shize Biological Technology Company Information
10.15.2 Shanghai Shize Biological Technology Introduction and Business Overview
10.15.3 Shanghai Shize Biological Technology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Shanghai Shize Biological Technology Afutuzumab Products Offered
10.15.5 Shanghai Shize Biological Technology Recent Development
10.16 Shanghai Yifei Biotechnology
10.16.1 Shanghai Yifei Biotechnology Company Information
10.16.2 Shanghai Yifei Biotechnology Introduction and Business Overview
10.16.3 Shanghai Yifei Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Shanghai Yifei Biotechnology Afutuzumab Products Offered
10.16.5 Shanghai Yifei Biotechnology Recent Development
10.17 Shanghai Yu'ang Chemical
10.17.1 Shanghai Yu'ang Chemical Company Information
10.17.2 Shanghai Yu'ang Chemical Introduction and Business Overview
10.17.3 Shanghai Yu'ang Chemical Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Shanghai Yu'ang Chemical Afutuzumab Products Offered
10.17.5 Shanghai Yu'ang Chemical Recent Development
10.18 Tianmen Hengchang Chemical
10.18.1 Tianmen Hengchang Chemical Company Information
10.18.2 Tianmen Hengchang Chemical Introduction and Business Overview
10.18.3 Tianmen Hengchang Chemical Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Tianmen Hengchang Chemical Afutuzumab Products Offered
10.18.5 Tianmen Hengchang Chemical Recent Development
10.19 Wuhan Sunrise Technology Development
10.19.1 Wuhan Sunrise Technology Development Company Information
10.19.2 Wuhan Sunrise Technology Development Introduction and Business Overview
10.19.3 Wuhan Sunrise Technology Development Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Wuhan Sunrise Technology Development Afutuzumab Products Offered
10.19.5 Wuhan Sunrise Technology Development Recent Development
10.20 Wuhan Yingnuo Pharmaceutical Technology
10.20.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
10.20.2 Wuhan Yingnuo Pharmaceutical Technology Introduction and Business Overview
10.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Products Offered
10.20.5 Wuhan Yingnuo Pharmaceutical Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Afutuzumab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Afutuzumab Industrial Chain Analysis
11.4 Afutuzumab Market Dynamics
11.4.1 Afutuzumab Industry Trends
11.4.2 Afutuzumab Market Drivers
11.4.3 Afutuzumab Market Challenges
11.4.4 Afutuzumab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Afutuzumab Distributors
12.3 Afutuzumab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Patent
Table 2. Major Company of Generic
Table 3. Global Afutuzumab Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Afutuzumab Sales by Type (2024-2024) & (Kg)
Table 5. Global Afutuzumab Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Afutuzumab Sales by Type (2024-2024) & (US& Million)
Table 7. Global Afutuzumab Market Share in Value by Type (2024-2024)
Table 8. Global Afutuzumab Price by Type (2024-2024) & (US$/Kg)
Table 9. Global Afutuzumab Sales by Type (2024-2034) & (Kg)
Table 10. Global Afutuzumab Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Afutuzumab Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Afutuzumab Sales Market Share in Value by Type (2024-2034)
Table 13. Global Afutuzumab Price by Type (2024-2034) & (US$/Kg)
Table 14. North America Afutuzumab Sales by Type (2024-2024) & (Kg)
Table 15. North America Afutuzumab Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Afutuzumab Sales (Kg) by Type (2024-2024)
Table 17. Europe Afutuzumab Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Afutuzumab Sales (Kg) by Type (2024-2024)
Table 19. Asia-Pacific Afutuzumab Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Afutuzumab Sales (Kg) by Type (2024-2024)
Table 21. Latin America Afutuzumab Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Afutuzumab Sales (Kg) by Type (2024-2024)
Table 23. Middle East and Africa Afutuzumab Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Afutuzumab Sales by Company (2024-2024) & (Kg)
Table 25. Global Afutuzumab Sales Share by Company (2024-2024)
Table 26. Global Afutuzumab Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Afutuzumab Revenue Share by Company (2024-2024)
Table 28. Global Market Afutuzumab Price by Company (2024-2024) & (US$/Kg)
Table 29. Global Afutuzumab Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Afutuzumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Afutuzumab as of 2022)
Table 32. Date of Key Manufacturers Enter into Afutuzumab Market
Table 33. Key Manufacturers Afutuzumab Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Afutuzumab Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Afutuzumab Sales by Region (2024-2024) & (Kg)
Table 37. Global Afutuzumab Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Afutuzumab Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Afutuzumab Sales Market Share in Value by Region (2024-2024)
Table 40. Global Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 41. Global Afutuzumab Sales by Region (2024-2034) & (Kg)
Table 42. Global Afutuzumab Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Afutuzumab Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Afutuzumab Sales Market Share in Value by Region (2024-2034)
Table 45. Global Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2034)
Table 46. Global Afutuzumab Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Afutuzumab Sales by Application (2024-2024) & (Kg)
Table 48. Global Afutuzumab Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Afutuzumab Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Afutuzumab Sales Market Share in Value by Application (2024-2024)
Table 51. Global Afutuzumab Price by Application (2024-2024) & (US$/Kg)
Table 52. Global Afutuzumab Sales by Application (2024-2034) & (Kg)
Table 53. Global Afutuzumab Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Afutuzumab Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Afutuzumab Sales Market Share in Value by Application (2024-2034)
Table 56. Global Afutuzumab Price by Application (2024-2034) & (US$/Kg)
Table 57. North America Afutuzumab Sales by Application (2024-2024) (Kg)
Table 58. North America Afutuzumab Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Afutuzumab Sales by Application (2024-2024) (Kg)
Table 60. Europe Afutuzumab Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Afutuzumab Sales by Application (2024-2024) (Kg)
Table 62. Asia-Pacific Afutuzumab Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Afutuzumab Sales by Application (2024-2024) (Kg)
Table 64. Latin America Afutuzumab Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Afutuzumab Sales by Application (2024-2024) (Kg)
Table 66. Middle East and Africa Afutuzumab Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Afutuzumab Sales by Country (2024-2024) & (Kg)
Table 68. North America Afutuzumab Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Afutuzumab Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Afutuzumab Sales Market Share in Value by Country (2024-2024)
Table 71. North America Afutuzumab Sales by Country (2024-2034) & (Kg)
Table 72. North America Afutuzumab Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Afutuzumab Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Afutuzumab Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Afutuzumab Sales by Country (2024-2024) & (Kg)
Table 76. Europe Afutuzumab Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Afutuzumab Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Afutuzumab Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Afutuzumab Sales by Country (2024-2034) & (Kg)
Table 80. Europe Afutuzumab Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Afutuzumab Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Afutuzumab Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Afutuzumab Sales by Region (2024-2024) & (Kg)
Table 84. Asia-Pacific Afutuzumab Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Afutuzumab Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Afutuzumab Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Afutuzumab Sales by Region (2024-2034) & (Kg)
Table 88. Asia-Pacific Afutuzumab Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Afutuzumab Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Afutuzumab Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Afutuzumab Sales by Country (2024-2024) & (Kg)
Table 92. Latin America Afutuzumab Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Afutuzumab Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Afutuzumab Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Afutuzumab Sales by Country (2024-2034) & (Kg)
Table 96. Latin America Afutuzumab Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Afutuzumab Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Afutuzumab Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Afutuzumab Sales by Country (2024-2024) & (Kg)
Table 100. Middle East and Africa Afutuzumab Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Afutuzumab Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Afutuzumab Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Afutuzumab Sales by Country (2024-2034) & (Kg)
Table 104. Middle East and Africa Afutuzumab Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Afutuzumab Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Afutuzumab Sales Market Share in Value by Country (2024-2034)
Table 107. BOC Sciences Company Information
Table 108. BOC Sciences Introduction and Business Overview
Table 109. BOC Sciences Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 110. BOC Sciences Afutuzumab Product
Table 111. BOC Sciences Recent Development
Table 112. Carbosynth Company Information
Table 113. Carbosynth Introduction and Business Overview
Table 114. Carbosynth Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 115. Carbosynth Afutuzumab Product
Table 116. Carbosynth Recent Development
Table 117. Roche Group Company Information
Table 118. Roche Group Introduction and Business Overview
Table 119. Roche Group Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 120. Roche Group Afutuzumab Product
Table 121. Roche Group Recent Development
Table 122. TargetMol Chemicals Company Information
Table 123. TargetMol Chemicals Introduction and Business Overview
Table 124. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 125. TargetMol Chemicals Afutuzumab Product
Table 126. TargetMol Chemicals Recent Development
Table 127. Wonda Science Company Information
Table 128. Wonda Science Introduction and Business Overview
Table 129. Wonda Science Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 130. Wonda Science Afutuzumab Product
Table 131. Wonda Science Recent Development
Table 132. Absin Bioscience Company Information
Table 133. Absin Bioscience Introduction and Business Overview
Table 134. Absin Bioscience Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 135. Absin Bioscience Afutuzumab Product
Table 136. Absin Bioscience Recent Development
Table 137. Chunchuang (Wuhan) Technology Company Information
Table 138. Chunchuang (Wuhan) Technology Introduction and Business Overview
Table 139. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 140. Chunchuang (Wuhan) Technology Afutuzumab Product
Table 141. Chunchuang (Wuhan) Technology Recent Development
Table 142. Hubei Kele Fine Chemical Company Information
Table 143. Hubei Kele Fine Chemical Introduction and Business Overview
Table 144. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 145. Hubei Kele Fine Chemical Afutuzumab Product
Table 146. Hubei Kele Fine Chemical Recent Development
Table 147. Jiangxi Ruiweier Biotechnology Company Information
Table 148. Jiangxi Ruiweier Biotechnology Introduction and Business Overview
Table 149. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 150. Jiangxi Ruiweier Biotechnology Afutuzumab Product
Table 151. Jiangxi Ruiweier Biotechnology Recent Development
Table 152. Qingdao Jieshikang Biotechnology Company Information
Table 153. Qingdao Jieshikang Biotechnology Introduction and Business Overview
Table 154. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 155. Qingdao Jieshikang Biotechnology Afutuzumab Product
Table 156. Qingdao Jieshikang Biotechnology Recent Development
Table 157. Shanghai Biochempartner Company Information
Table 158. Shanghai Biochempartner Introduction and Business Overview
Table 159. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 160. Shanghai Biochempartner Afutuzumab Product
Table 161. Shanghai Biochempartner Recent Development
Table 162. Shanghai Macklin Biochemical Company Information
Table 163. Shanghai Macklin Biochemical Introduction and Business Overview
Table 164. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 165. Shanghai Macklin Biochemical Afutuzumab Product
Table 166. Shanghai Macklin Biochemical Recent Development
Table 167. Shanghai Qiming Biotechnology Company Information
Table 168. Shanghai Qiming Biotechnology Introduction and Business Overview
Table 169. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 170. Shanghai Qiming Biotechnology Afutuzumab Product
Table 171. Shanghai Qiming Biotechnology Recent Development
Table 172. Shanghai Saimai Biotechnology Company Information
Table 173. Shanghai Saimai Biotechnology Introduction and Business Overview
Table 174. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 175. Shanghai Saimai Biotechnology Afutuzumab Product
Table 176. Shanghai Saimai Biotechnology Recent Development
Table 177. Shanghai Shize Biological Technology Company Information
Table 178. Shanghai Shize Biological Technology Introduction and Business Overview
Table 179. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 180. Shanghai Shize Biological Technology Afutuzumab Product
Table 181. Shanghai Shize Biological Technology Recent Development
Table 182. Shanghai Yifei Biotechnology Company Information
Table 183. Shanghai Yifei Biotechnology Introduction and Business Overview
Table 184. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 185. Shanghai Yifei Biotechnology Afutuzumab Product
Table 186. Shanghai Yifei Biotechnology Recent Development
Table 187. Shanghai Yu'ang Chemical Company Information
Table 188. Shanghai Yu'ang Chemical Introduction and Business Overview
Table 189. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 190. Shanghai Yu'ang Chemical Afutuzumab Product
Table 191. Shanghai Yu'ang Chemical Recent Development
Table 192. Tianmen Hengchang Chemical Company Information
Table 193. Tianmen Hengchang Chemical Introduction and Business Overview
Table 194. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 195. Tianmen Hengchang Chemical Afutuzumab Product
Table 196. Tianmen Hengchang Chemical Recent Development
Table 197. Wuhan Sunrise Technology Development Company Information
Table 198. Wuhan Sunrise Technology Development Introduction and Business Overview
Table 199. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 200. Wuhan Sunrise Technology Development Afutuzumab Product
Table 201. Wuhan Sunrise Technology Development Recent Development
Table 202. Wuhan Yingnuo Pharmaceutical Technology Company Information
Table 203. Wuhan Yingnuo Pharmaceutical Technology Introduction and Business Overview
Table 204. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 205. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product
Table 206. Wuhan Yingnuo Pharmaceutical Technology Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Afutuzumab Market Trends
Table 210. Afutuzumab Market Drivers
Table 211. Afutuzumab Market Challenges
Table 212. Afutuzumab Market Restraints
Table 213. Afutuzumab Distributors List
Table 214. Afutuzumab Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Afutuzumab Product Picture
Figure 2. Global Afutuzumab Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Afutuzumab Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Afutuzumab Sales Status and Outlook (2024-2034) & (Kg)
Figure 5. Product Picture of Patent
Figure 6. Global Patent Sales YoY Growth (2024-2034) & (Kg)
Figure 7. Product Picture of Generic
Figure 8. Global Generic Sales YoY Growth (2024-2034) & (Kg)
Figure 9. Global Afutuzumab Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Afutuzumab Sales Market Share by Type in 2022 & 2034
Figure 11. North America Afutuzumab Sales Market Share in Volume by Type in 2022
Figure 12. North America Afutuzumab Sales Market Share in Value by Type in 2022
Figure 13. Europe Afutuzumab Sales Market Share in Volume by Type in 2022
Figure 14. Europe Afutuzumab Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Afutuzumab Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Afutuzumab Sales Market Share in Value by Type in 2022
Figure 17. Latin America Afutuzumab Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Afutuzumab Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Afutuzumab Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Afutuzumab Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Afutuzumab Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Afutuzumab Revenue in 2022
Figure 23. Afutuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Chronic Lymphocytic Leukemia
Figure 25. Global Chronic Lymphocytic Leukemia Sales YoY Growth (2024-2034) & (Kg)
Figure 26. Product Picture of Follicular Lymphoma
Figure 27. Global Follicular Lymphoma Sales YoY Growth (2024-2034) & (Kg)
Figure 28. Global Afutuzumab Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Afutuzumab Sales Market Share by Application in 2022 & 2034
Figure 30. North America Afutuzumab Sales Market Share in Volume by Application in 2022
Figure 31. North America Afutuzumab Sales Market Share in Value by Application in 2022
Figure 32. Europe Afutuzumab Sales Market Share in Volume by Application in 2022
Figure 33. Europe Afutuzumab Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Afutuzumab Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Afutuzumab Sales Market Share in Value by Application in 2022
Figure 36. Latin America Afutuzumab Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Afutuzumab Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Afutuzumab Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Afutuzumab Manufacturing Cost Structure
Figure 41. Afutuzumab Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed